BULLFROG AI HOLDINGS, INC. Operating Expenses
BULLFROG AI HOLDINGS, INC. (BFRG) reported Operating Expenses of $1.53 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-14
- BULLFROG AI HOLDINGS, INC. operating expenses for the quarter ending 2026-06-30 was $1.53M, a 3.37% increase year-over-year.
- BULLFROG AI HOLDINGS, INC. operating expenses for the quarter ending 2026-03-31 was $1.61M, a 21.49% decline year-over-year.
- BULLFROG AI HOLDINGS, INC. operating expenses for the quarter ending 2025-12-31 was $1.50M, a 15.27% decline year-over-year.
- BULLFROG AI HOLDINGS, INC. operating expenses for the quarter ending 2025-09-30 was $1.59M, a 12.91% decline year-over-year.
- BULLFROG AI HOLDINGS, INC. operating expenses for fiscal 2025 was $6.62M, a 8.57% decline from fiscal 2024.
- BULLFROG AI HOLDINGS, INC. operating expenses for fiscal 2024 was $7.24M, a 33.33% increase from fiscal 2023.
- BULLFROG AI HOLDINGS, INC. operating expenses for fiscal 2023 was $5.43M, a 120.18% increase from fiscal 2022.
- BULLFROG AI HOLDINGS, INC. operating expenses for fiscal 2022 was $2.47M, a 343.85% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.53M 10-Q · filed 2026-08-14 | $3.14M 10-Q · filed 2026-08-14 | $4.64M derived: sum of 3 quarters · filed 2026-08-14 | $6.22M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $1.61M 10-Q · filed 2026-05-14 | $3.11M derived: sum of 2 quarters · filed 2026-05-14 | $4.70M derived: sum of 3 quarters · filed 2026-05-14 | $6.17M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $3.08M derived: sum of 2 quarters · filed 2026-03-19 | $4.56M derived: sum of 3 quarters · filed 2026-08-14 | $6.62M 10-K · filed 2026-03-19 |
| 2025-09-30 | $1.59M 10-Q · filed 2025-11-14 | $3.06M derived: sum of 2 quarters · filed 2026-08-14 | $5.12M 10-Q · filed 2025-11-14 | $6.89M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $1.48M 10-Q · filed 2026-08-14 | $3.53M 10-Q · filed 2026-08-14 | $5.30M derived: sum of 3 quarters · filed 2026-08-14 | $7.12M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $2.06M 10-Q · filed 2026-05-14 | $3.83M derived: sum of 2 quarters · filed 2026-05-14 | $5.65M derived: sum of 3 quarters · filed 2026-05-14 | $7.33M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $3.59M derived: sum of 2 quarters · filed 2026-03-19 | $5.27M derived: sum of 3 quarters · filed 2026-03-19 | $7.24M 10-K · filed 2026-03-19 |
| 2024-09-30 | $1.82M 10-Q · filed 2025-11-14 | $3.50M derived: sum of 2 quarters · filed 2025-11-14 | $5.47M 10-Q · filed 2025-11-14 | $6.80M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $1.68M 10-Q · filed 2025-08-13 | $3.65M 10-Q · filed 2025-08-13 | $4.98M derived: sum of 3 quarters · filed 2025-08-13 | $6.35M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $1.97M 10-Q · filed 2025-05-13 | $3.30M derived: sum of 2 quarters · filed 2025-05-13 | $4.67M derived: sum of 3 quarters · filed 2025-05-13 | $6.20M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $2.70M derived: sum of 2 quarters · filed 2025-03-14 | $4.24M derived: sum of 3 quarters · filed 2025-03-14 | $5.43M 10-K · filed 2025-03-14 |
| 2023-09-30 | $1.36M 10-Q · filed 2024-11-08 | $2.90M derived: sum of 2 quarters · filed 2024-11-08 | $4.09M 10-Q · filed 2024-11-08 | $4.68M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $1.54M 10-Q · filed 2024-08-07 | $2.73M 10-Q · filed 2024-08-07 | $3.32M derived: sum of 3 quarters · filed 2024-08-07 | $3.96M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $1.19M 10-Q · filed 2024-05-10 | $1.78M derived: sum of 2 quarters · filed 2024-05-10 | $2.42M derived: sum of 3 quarters · filed 2024-05-10 | $3.11M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $592.24K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $1.23M derived: sum of 2 quarters · filed 2024-03-29 | $1.91M derived: sum of 3 quarters · filed 2024-03-29 | $2.47M 10-K · filed 2024-03-29 |
| 2022-09-30 | $640.55K 10-Q · filed 2023-11-14 | $1.32M derived: sum of 2 quarters · filed 2023-11-14 | $1.87M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $681.96K 10-Q · filed 2023-08-14 | $1.23M 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | $550.25K 10-Q · filed 2023-05-24 | |||
| 2021-12-31 | $555.36K 10-K · filed 2023-04-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B |